Bod Science Ltd (ASX: BOD) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Bod Science Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.26 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 177.34 million
Earnings per share -0.056
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Bod Science Ltd (ASX: BOD)
    Latest News

    Healthcare Shares

    Why a COVID-19 trial is exciting BOD (ASX:BOD) investors today?

    A clinical trial into the use of medicinal cannabis for long-term COVID-19 is going ahead.

    Read more »

    three excited doctors with hands in the air
    Share Gainers

    These 3 ASX Healthcare shares are running hot today

    These ASX Healthcare shares have led the way today along with metals and mining.

    Read more »

    women working with medicinal marijuana, indicating a share price movement in ASX cannabis shares
    Share Market News

    Why the Bod (ASX:BDA) share price is climbing today

    This ASX cannabis stock is on the rise today after a promising sales update

    Read more »

    A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
    Cannabis Shares

    Up 21%, why the Bod (ASX:BDA) share price is smoking the market today

    The Bod (ASX: BDA) share price has surged 21% today following the release of a positive trading update. Here's what…

    Read more »

    A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
    Share Market News

    Bod (ASX:BDA) share price soars on United States market entry

    The Bod Australia Ltd (ASX: BDA) share price is soaring after the company announced its first purchased order for the…

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Share Market News

    Why the Bod (ASX:BDA) share price is tracking 5% higher today

    The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive…

    Read more »

    ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
    Share Market News

    Why the Bod (ASX:BDA) share price is soaring 11%

    The Bod share price is soaring 12% today as the company announced strong sales in the second half of CY2020.

    Read more »

    hand on touch screen lit up by a share price chart moving higher
    Share Gainers

    Why Atomos, BOD Australia, Galaxy, & Zebit shares are racing higher

    Atomos Ltd (ASX:AMS) and Galaxy Resources Limited (ASX:GXY) shares are two of four racing higher on Thursday...

    Read more »

    asx share price rise represented by red paper plane flying away from other white paper planes
    Share Market News

    Why the Bod (ASX:BDA) share price is rising 5% today

    The Bod Australia Ltd (ASX: BDA) share price is climbing 5.7% higher as the company secured purchase orders for the…

    Read more »

    Share Market News

    Why the BOD (ASX:BDA) share price is on the run today

    The BOD Australia Ltd (ASX: BDA) share price is on the run today following a positive update from the company…

    Read more »

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price
    Share Market News

    BOD (ASX:BDA) share price soars 8% on product launch

    The Bod share price was flying today as the company announced its entrance into the Netherlands market. We take closer…

    Read more »

    wooden blocks with percentage signs being built into towers of increasing height
    Share Market News

    Bod share price surges 5% on record revenue growth

    The Bod Australia Ltd (ASX: BDA) share price is surging today on positive numbers from the company's quarterly report. We…

    Read more »

    BOD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Bod Science Ltd

    Bod Science Ltd is a healthcare company combining the power of nature and science to deliver cannabis-derived health and skincare products, designed to improve lives and transform the medicinal cannabis, CBD, and hemp market. The firm is focused on cannabis drug development and products. The company is focused on progressing Research and Development and a defined clinical trial pathway to commercialize and deliver premium, scientifically trusted products for the consumer andmedical markets.

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Dec 2023 Akash Bedi Expiry 500,000 $12,000
    Options expired. As per announcement on 08-02-2024
    06 Oct 2023 David Baker Issued 1,875,000 $150,000
    06 Oct 2023 David Baker Issued 937,500 $64,687
    23 Aug 2023 Joanne (Jo) Patterson Cancelled 361,179 $28,894
    Cancellation of securities. 1,109,439 Rights
    23 Aug 2023 George Livery Expiry 1,300,000 $104,000
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Lewis Baker Non-Executive DirectorNon-Executive Chairman Apr 2022
    Mr Baker is a commercial advisor and company director with over 40 years' experience in law, investment banking, public company leadership and corporate governance. He has industry knowledge across a range of sectors and an understanding of financial markets. David is also a co-founder of Baker Cook Advisory which is a boutique provider of outsourced legal, commercial and governance advice and mediation services for corporations and government agencies. He is Chair of the Risk Committee.
    Ms Joanne (Jo) Patterson Chief Executive OfficerExecutive Director Oct 2016
    Ms Patterson has over 20 years' experience in business and corporate strategy with exposure in Australia and international markets. She has developed a number of businesses from start-up as well as driving established organisations towards growth and merger trajectories. She has been recognised as a business executive by winning a number of business awards and her acumen is evidenced in the success of previous companies in the technology, advertising and beauty sectors. Jo has held multiple CEO and Managing Director roles over her career.

    Mr George Livery Non-Executive Director Sep 2018
    Mr Livery has enjoyed executive roles across industries for the last 30 years, both domestically and internationally as an expat. A C-level executive for the last 25 years, George's career has included CEO of Village Cinemas Australia, COO of Village International, Commercial Director at Hoyts Ltd, Director of Operations (Non-Academic Services) at University of Sydney's USU, both Commercial Director at Swisse Vitamins and Director of Strategy & Corporate at Swisse Wellness Group. Most recently George has enjoyed Chairperson, Non-executive Director and CoSec roles on ASX listed and private companies. George also led the corporate integration of Swisse Wellness into the Hong Kong listed H&H Group of companies and enjoyed a dual role during that time as Group Senior VP Legal and Risk. George has held board positions across a number of industries including the NFP sector. He is Member of the Risk Committee.
    Mr Akash Bedi Non-Executive Director Jul 2019
    Mr Bedi is the Chief Strategy and Operations Officer of Health & Happiness International Holdings Limited from December 2019. He joined the Group in July 2018 as Senior Director of Strategy and Corporate Affairs. As part of his role at the Group, Akash is responsible for overall procurement, logistics, production and supply chain for all H&H Group brands and is also responsible for developing business strategies and roadmaps, identifying growth opportunities and strengthening the Group's industry and market insight capabilities. In the last three years, he has been leading and managing the Swisse business for India and the Middle Eastern market. Akash also leads mergers and acquisitions for the Group and strategic investments for NewH2 Fund (the corporate venture subsidiary of the Group), which focuses on investing in global startups and high-growth companies with technologies and businesses of strategic importance. Previously Akash held the position of Director, Global Consumer & Retail at HSBC for over 10 years from May 2008 where he worked on mergers and acquisition transactions from its global offices in New York, London and Hong Kong. His other current directorships include Else Nutrition Holdings, Inc. He is Member of the Risk Committee.
    Ms Carlie Hodges Company Secretary Jan 2023
    Adrian Sturrock Chief Financial Officer
    Craig Weller Chief Technology Officer
    Carlie Hodges Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 29,078,325 16.57%
    Dutch Ink (2010) Pty Ltd 15,278,286 8.71%
    Health And Beauty Enterprise Pty Limited 6,375,000 3.63%
    Noir Ted Pty Ltd 4,852,329 2.77%
    Citicorp Nominees Pty Limited 4,506,536 2.57%
    Baker Cook Advisory Pty Ltd 4,500,000 2.56%
    Awj Family Pty Ltd 4,445,346 2.53%
    Gp Securities Pty Ltd 3,796,066 2.16%
    Btt Sciences Ltd 3,750,000 2.14%
    S3 Consortium Pty Ltd 3,535,112 2.01%
    Hendo Family Superannuation Pty Ltd 2,235,295 1.27%
    Avl Nominees Pty Ltd 2,000,000 1.14%
    Lotaka Pty Ltd 2,000,000 1.14%
    Biatan Pty Ltd 1,968,419 1.12%
    Jimzbal Pty Ltd 1,710,000 0.97%
    Toucan Trading Pty Ltd 1,562,500 0.89%
    Lake Pacific Pty Ltd 1,450,000 0.83%
    Gofour Sail Pty Ltd 1,450,000 0.83%
    Mrs Emma Isabell Nixon 1,203,209 0.69%
    Vagg Family Pty Ltd 1,165,173 0.66%